List view / Grid view
25 May 2017 | By Niamh Marriott, Junior Editor
The European Commission has granted marketing authorisation for AstraZeneca’s Brilique (ticagrelor) orodispersible tablets (ODT) as a new formulation...
25 May 2017 | By Niamh Marriott, Junior Editor
The study assessed the efficacy of a drug candidate proposed by BenevolentAI’s artificial Intelligence technology for Motor Neuron Disease (MND)...
25 May 2017 | By Wickham Laboratories
Join us for a free webinar to discuss the challenges of transitioning from in-vivo to in-vitro methods...
24 May 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker)...
24 May 2017 | By Niamh Marriott, Junior Editor
AstraZeneca has entered into an agreement with Recordati for the commercial rights to Seloken/Seloken ZOK treatments in Europe...
24 May 2017 | By Niamh Marriott, Junior Editor
A novel tablet is helping heart failure patients to manage their disease including drug dosages, according to new research...
24 May 2017 | By Niamh Marriott, Junior Editor
In a new study, Uppsala University researchers have successfully measured 92 different proteins in millimetre-sized circles punched out of dried samples...
24 May 2017 | By Niamh Marriott, Junior Editor
The FDA has approved two new indications for Merck’s Keytruda (pembrolizumab), the company’s anti-PD-1 therapy, for bladder cancer...
23 May 2017 | By Niamh Marriott, Junior Editor
Grifols now provides European countries accepting products with the CE marking with a test to detect the presence of the Zika virus in donated blood.
23 May 2017 | By Niamh Marriott, Junior Editor
The State Patent Bureau of the Republic of Lithuania (SPB) and Kaunas University of Technology National Innovation and Entrepreneurship Centre (KTU NIEC) has signed the collaboration agreement, which laid foundation for the new Patent Library – PATLIB Centre. This will be the first time, when a PATLIB Centre is established…
23 May 2017 | By Niamh Marriott, Junior Editor
Biosimilar medicines have dramatically increased patient access to biological medicines, according to the recently published QuintilesIMS report...
22 May 2017 | By Niamh Marriott, Junior Editor
Approximately one in four adults prescribed an antibiotic in an outpatient setting for community-acquired pneumonia does not respond to treatment...
22 May 2017 | By Niamh Marriott, Junior Editor
Pfizer have announced an extension of their collaboration to further broaden access to Pfizer’s all-in-one injectable contraceptive...
22 May 2017 | By Niamh Marriott, Junior Editor
Bonesupport, the Scandinavian medical technology company, has enrolled their first patient at the University of Texas Health Science Center at San Antonio into the company’s pivotal Investigational Device Exemption (IDE) trial. Cerament G is an injectable antibiotic-eluting bone graft substitute that has proven remodelling capabilities and provides local sustained delivery…
22 May 2017 | By Niamh Marriott, Junior Editor
The first high energy proton beam therapy system to be installed in the UK has arrived at The Rutherford Cancer Centre, South Wales.
